Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden

Sandra HalldorsdottirDepartment of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden; View further author information

Hanna DahlstrandDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenView further author information

Karin StålbergDepartment of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden; Correspondence[email protected]
View further author information

Pages 225-229 | Received 10 Oct 2018, Accepted 01 Nov 2018, Published online: 10 Dec 2018

Cite this article
https://doi.org/10.1080/03009734.2018.1544597
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Rodriguez M, Shoupe D. Surgical menopause. Endocrinol Metab Clin North Am. 2015;44:531–42.
PubMed Web of Science ®Google Scholar
Rossouw JE, Prentice RL, Manson JE, Ko M, Lacroix AZ, Margolis KL, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–78.
PubMed Web of Science ®Google Scholar
Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, et al. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone. 2004;34:728–35.
PubMed Web of Science ®Google Scholar
The North American Menopause Society (NAMS). The 2012 hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19:257–71.
PubMed Web of Science ®Google Scholar
Socialstyrelsen cancer incidence in Sweden 1970–2014.
Google Scholar
Holinka CE, Hata H, Kuramoto H, Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line. J Steroid Biochem. 1986;24:85–9.
PubMedGoogle Scholar
Chapman JA, DiSaia PJ, Osann K, Roth PD, Gillotte DL, Berman ML. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol. 1996;175:1195–200.
PubMed Web of Science ®Google Scholar
Barakat RR. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24:587–92.
PubMed Web of Science ®Google Scholar
Suriano KA, McHale M, McLaren CE, Li KT, Re A, DiSaia PJ. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol. 2001;97:555–60.
PubMed Web of Science ®Google Scholar
Swedish National Guidelines for endometrial cancer. 2011. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/gynekologi/livmoderkropp/vardprogram/gallande-vardprogram/
Google Scholar
Mascarenhas C, Lambe M, Bellocco R, Bergfeldt K, Riman T, Persson I, et al. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival. Int J Cancer. 2006;119:2907–15.
PubMed Web of Science ®Google Scholar
Guidozzi F, Daponte A. Estrogen replacement therapy for ovarian carcinoma survivors: a randomized controlled trial. Cancer. 1999;86:1013–18.
PubMed Web of Science ®Google Scholar
Eeles RA, Tan S, Wiltshaw E, Fryatt I, A’Hern RP, Shepherd JH, et al. Hormone replacement therapy and survival after surgery for ovarian cancer. BMJ. 1991;302:259–62.
PubMed Web of Science ®Google Scholar
Eeles RA, Morden JP, Gore M, Mansi J, Glees J, Wenczl M, et al. Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial. J Clin Oncol. 2015;33:4138–44.
PubMed Web of Science ®Google Scholar
Swedish National Guidelines for ovarian cancer. 2015. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/gynekologi/aggstock/vardprogram/gallande-vardprogram-aggstock cancer/
Google Scholar
Hancke K, Foeldi M, Zahradnik HP, Gitsch G, Gilbert L, Denschlag D. Estrogen replacement therapy after endometrial cancer: a survey of physicians’ prescribing practice. Climacteric. 2010;13:271–7.
PubMed Web of Science ®Google Scholar
Yokoyama Y, Ito K, Takamatsu K, Takehara K, Nakanishi T, Harano K, et al. How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey. Int J Clin Oncol. 2015;20:997–1004.
PubMed Web of Science ®Google Scholar
Socialstyrelsen: Statistik över hälso-och sjukvårdspersonal. 2015. Available from: shttps://www.socialstyrelsen.se/publikationer2016/2016-10-15
Google Scholar
Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 1996;348:977–80.
PubMed Web of Science ®Google Scholar
Rossouw J, Andersson G. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321–33.
PubMed Web of Science ®Google Scholar
Marsden J. Long-term benefits and risks of HRT: breast cancer. Post Reprod Health. 2016;22:85–91.
PubMedGoogle Scholar
Lacroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305:1305–14.
PubMed Web of Science ®Google Scholar
Lambe M, Wigertz A, Holmqvist M. Reduction in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years. Breast Cancer Res Treat. 2010;121:679–83.
PubMed Web of Science ®Google Scholar
Socialstyrelsen statistic database for drugs. 2010 and 2015. Available from: https://www.socialstyrelsen.se/statistik/statistikefteramne/lakemedel
Google Scholar
Zhang Y-L, Chen J-H, Lu W, Li B-L, Zhu Q-Y, Wan X-P. Efficacy of postoperative hormone replacement therapy on prognosis of patients with serous ovarian carcinoma. Chin Med J (Engl). 2016;129:1316.
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines—a survey in Sweden

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date